Abstract
No public abstract is available from the verified source records.
Sabnam Parveen, Sheikh Murtuja, Mamata R. Rakhade, Azim Ansari, Mohd Usman, Avantika Tyagi, Rikeshwer Prasad Dewangan, Vishnu Nayak Badavath, Ritchu Babbar
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Recent insights into synthesis, biological activities, structure activity relationship and molecular interactions of thiazolidinone hybrids: a systematic review
10.1080/00397911.2023.2269582 · 2024
Heterocycle compounds with antimicrobial activity
10.2174/1381612826666200206093815 · 2020
Design, synthesis, spectroscopic characterization of new pyrazole carbothioamides as antifungal and antibacterial candidates
2021
Synthesis and antimicrobial activity of thiophene-based heterocycles derived from thiophene-2-carbohydrazide
10.4155/fmc-2023-0304 · 2024
Synthetic and medicinal perspective of thiazolidinones: a review
10.1016/j.bioorg.2017.10.014 · 2017
Synthesis and in silico evaluation of thiazole, thiazolidinone, and pyrimidinethione candidates bearing a benzo [h] quinoline scaffold as potential antiproliferative agents
10.1080/10406638.2025.2552424 · 2026
Straightforward synthesis and in silico evaluation of pyrazolylthiazolidinone derivatives as prospective antiproliferative agents
10.1016/j.bioorg.2025.109036 · 2025
Novel 4-thiazolidinone derivatives as anti-infective agents: synthesis, characterization, and antimicrobial evaluation
10.1155/2016/8086762 · 2016
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
Design, synthesis and in vitro antimicrobial activity of furan-based pyrimidine-thiazolidinones as potential bioactive molecules
2023
Identification of CH2-linked quinolone-aminopyrimidine hybrids as potent anti-MRSA agents: low resistance potential and lack of cross-resistance with fluoroquinolone antibiotics
10.1016/j.ejmech.2024.116399 · 2024
Antibacterial activity and DNA gyrase inhibitory potency of some novel pyrazolo [1, 5-a] pyrimidine-based thiazolidin-4-one hybrids linked to aryl units
10.1080/00397911.2026.2634260 · 2026
Synthesis, characterization, DFT, antibacterial, ADME-T properties, and molecular docking of new N-functionalized thiazolidinones
10.1016/j.molstruc.2024.138004 · 2024
Synthesis and antibiofilm evaluation of N-acyl-2-aminopyrimidine derivatives against Acinetobacter baumannii
10.1016/j.bmc.2022.117095 · 2022
Design, synthesis, molecular dynamic simulation studies, and antibacterial evaluation of new spirocyclic aminopyrimidines
10.1016/j.molstruc.2023.134912 · 2023
Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases
10.4155/fmc-2017-0168 · 2018
Dihydrofolate reductase inhibitors as antibacterial agents
10.1016/j.bcp.2005.10.052 · 2006
Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors
10.1038/s41429-019-0240-6 · 2020
Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus
10.1107/s0907444909013936 · 2009
Propargyl-linked antifolates are dual inhibitors of Candida albicans and Candida glabrata
10.1021/jm401916j · 2014
Unveiling the antimicrobial activity of some new Quinazolindione-anchored pyrazole, chromene and/or furo [2, 3-b] indole hybrids through acylthiourea conjugate: synthesis, molecular docking, Semiempirical calculations and ADMET prediction
10.1016/j.rechem.2025.102175 · 2025
Hybrids of thiazolidinone with 1, 2, 3-triazole derivatives: design, synthesis, biological evaluation, in silico studies, molecular docking, molecular dynamics simulations, and ADMET profiling
10.1080/07391102.2022.2164357 · 2023
Thiazolidin-4-ones as potential antimicrobial agents: experimental and in silico evaluation
10.3390/molecules27061930 · 2022
Design, synthesis, and biological evaluation of novel thiazolidinone-containing quinoxaline-1, 4-di-N-oxides as antimycobacterial and antifungal agents
2020
4-Thiazolidinone derivatives as potent antimicrobial agents: microwave-assisted synthesis, biological evaluation and docking studies
10.1039/c4md00399c · 2015
N-terminally modified linear and branched spermine backbone dipeptidomimetics against planktonic and sessile methicillin-resistant Staphylococcus aureus
10.1128/aac.03391-14 · 2014
Design, synthesis and molecular modelling of novel 4-thiazolidinones of potential activity against gram positive bacteria
10.1007/s00044-012-0115-x · 2013
Synthesis and evaluation of antibacterial and antifungal activities of 4-thiazolidinones and 2-azetidinones derivatives from chalcone
10.1007/s00044-017-1837-6 · 2017
Synthesis, characterization and biological evaluation of thioureas, acylthioureas and 4-thiazolidinones as anticancer and antiviral agents
2017
Synthesis, in-vitro and in-silico study of novel thiazoles as potent antibacterial agents and MurB inhibitors
10.1002/ardp.201900309 · 2020
Design, synthesis and biological evaluation of new substituted 5-benzylideno-2-adamantylthiazol [3, 2-b][1, 2, 4] triazol-6 (5H) ones. Pharmacophore models for antifungal activity
2016
Computational analysis of novel 4-thiazolidinone derivatives as potential anti-breast cancer agents: docking, pharmacokinetics, and molecular dynamics study
2024
Identification of catechin as main protease inhibitor of SARS-CoV-2 omicron variant using molecular docking, molecular dynamics, PCA, DCCM, MM/GBSA and ADMET profiling
10.1080/14786419.2024.2421907 · 2026
Molecular dynamics simulation, free energy landscape and binding free energy computations in exploration the anti-invasive activity of amygdalin against metastasis
10.1016/j.cmpb.2020.105660 · 2020
No additional external references are available.